Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
14 items

Powerful enzyme that tamps down inflammation holds promise for protecting eyes in diabetes, premature birth

October 12, 2022

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

OMRF discovery holds potential for reversing vision loss

October 6, 2020

Oklahoma Medical Research Foundation scientists have identified a compound that could give birth to therapies for a host of eye diseases that include retinopathy of prematurity and diabetic retinopathy.
Colorful confocal image of endothelial cells and microglia

New treatment targets found for blinding retinal disease

August 10, 2020

When the eye isn’t getting enough oxygen in the face of common conditions like premature birth or diabetes, it can result in blindness. Scientists have identified new points where they may be able to enable recovery.
Severe ROP Avastin candidate

Very low-dose Avastin effective for preventing blindness in preterm infants

April 23, 2020

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
A fundus image

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
Small baby sleeping in hospital.

Tech that detects cause of preemie blindness gets federal nod

January 30, 2020

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.
NICU care providers take photos of a premature baby's retinas in the NEI-funded e-ROP study of telemedicine for retinopathy of prematurity. Photo credit: Children's Hospital of Philadelphia

Telemedicine catches blinding disease in premature babies

July 9, 2014

Telemedicine is an effective strategy to screen for the potentially blinding disease known as retinopathy of prematurity (ROP), according to a study funded by the National Eye Institute (NEI).
Grantee News

Light Exposure During Pregnancy Key to Normal Eye Development

January 16, 2014

Blood vessels that normally regress in mice before the eyelids open 10 days after birth persist if the mouse fetus receives insufficient light in the womb — showing that the eye needs light to develop during pregnancy.
NEI logo.

Strategy Confirmed to Help Doctors Determine When to Treat Retinopathy of Prematurity

April 12, 2010

Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children
NEI logo.

Early Treatment of Blinding Eye Disease in Infants Can Prevent Severe Vision Loss

December 8, 2003

An important clinical trial, sponsored by the National Eye Institute(NEI), a part of the National Institutes of Health (NIH), has provideddoctors with improved prognostic indicators and treatment options forretinopathy of prematurity.